Nebenwirkungen · Dafiro
Dafiro 5 mg/80 mg film-coated tablets Dafiro 5 mg/160 mg film-coated tablets Dafiro 10 mg/160 mg film-coated tablets · Abschnitt 4.8 · PDF-Seite 10–11
HOS-117785 · Präparat HOS-094689
10 Skin and Dermatitis bullous -- -- Not known subcutaneous Erythema Uncommon -- -- tissue disorders Erythema multiforme -- Very rare -- Exanthema Rare Uncommon -- Hyperhidrosis Rare Uncommon -- Photosensitivity reaction -- Uncommon -- Pruritus Rare Uncommon Not known Purpura -- Uncommon -- Rash Uncommon Uncommon Not known Skin discolouration -- Uncommon -- Urticaria and other forms of -- Very rare -- rash Exfoliative dermatitis -- Very rare -- Stevens-Johnson syndrome -- Very rare -- Quincke oedema -- Very rare -- Toxic Epidermal Necrolysis -- Not known -- Musculoskeletal Arthralgia Uncommon Uncommon -- and connective Back pain Uncommon Uncommon -- tissue disorders Joint swelling Uncommon -- -- Muscle spasm Rare Uncommon -- Myalgia -- Uncommon Not known Ankle swelling -- Common -- Sensation of heaviness Rare -- -- Renal and Blood creatinine increased -- -- Not known urinary disorders Micturition disorder -- Uncommon -- Nocturia -- Uncommon -- Pollakiuria Rare Uncommon -- Polyuria Rare -- -- Renal failure and -- -- Not known impairment Reproductive Impotence -- Uncommon -- system and Erectile dysfunction Rare -- -- breast disorders Gynaecomastia -- Uncommon -- General disorders Asthenia Common Uncommon -- and Discomfort, malaise -- Uncommon -- administration Fatigue Common Common Uncommon site conditions Facial oedema Common -- -- Flushing, hot flush Common -- -- Non cardiac chest pain -- Uncommon -- Oedema Common Common -- Oedema peripheral Common -- -- Pain -- Uncommon -- Pitting oedema Common -- -- Investigations Blood potassium increased -- -- Not known Weight increase -- Uncommon -- Weight decrease -- Uncommon --
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2025-11-19T13:43:00Z · SHA-256 79620834a2f80d9411f50ae6b7ff4251fbeff4573f3af37e14d730cfb3d0f1a2 · Passage 8fb9fedcf3b24c569646b1f8bba3f1223b31ce3b28e68e51a238ef02a0270c8d · Zeichen 6828–10830 im Abschnitt